KNIGHT CAPITOL CONSULTANTS

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$7.7M

Filings

316

Unique Clients

Active Period

2008–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$30,000	2	2
2025	$60,000	10	3
2024	$175,000	15	5
2023	$510,000	20	5
2022	$720,000	23	6
2021	$800,000	26	6
2020	$480,000	16	4
2019	$440,000	16	4
2018	$440,000	16	4
2017	$580,000	26	7
2016	$480,000	16	4
2015	$380,000	17	5
2014	$370,000	17	4
2013	$360,000	12	3
2012	$330,000	12	3
2011	$330,000	14	5
2010	$460,000	22	5
2009	$420,000	16	4
2008	$310,000	20	4

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
UNITED NATURAL PRODUCTS ALLIANCE	$1,300,000	71	2009–2026
SANOFI US SERVICES INC (FORMERLY KNOWN AS "SANOFI-AVENTIS U S INC )	$1,150,000	41	2008–2017
INDIVIOR INC.	$1,090,000	29	2017–2024
CNO FINANCIAL GROUP	$930,000	55	2010–2026
GENZYME CORPORATION	$920,000	32	2008–2015
EQUASHIELD LLC	$720,000	35	2017–2025
REGENXBIO	$665,000	13	2021–2024
BRAEBURN PHARMACEUTICALS, INC.	$270,000	10	2015–2017
PHRMA	$240,000	11	2008–2011
PERSPECTUM	$230,000	7	2021–2022
PERNIX THERAPEUTICS HOLDINGS, LLC	$80,000	5	2017
SAP AMERICA INC.	$80,000	7	2008

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	261
HOUSE OF REPRESENTATIVES	249
Centers For Disease Control & Prevention (CDC)	25
Health & Human Services, Dept of (HHS)	25
Food & Drug Administration (FDA)	12
Federal Trade Commission (FTC)	8
Natl Institutes of Health (NIH)	6
Office of Natl Drug Control Policy (NDCP)	5
Centers For Medicare and Medicaid Services (CMS)	2
Drug Enforcement Administration (DEA)	2
Justice, Dept of (DOJ)	2

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	169
Budget/Appropriations	Budget/Appropriations	119
Medicare/Medicaid	Medicare/Medicaid	101
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	93
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	55
Pharmacy	Pharmacy	54
Copyright/Patent/Trademark	Copyright/Patent/Trademark	39
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	37
Agriculture	Agriculture	33
Alcohol and Drug Abuse	Alcohol and Drug Abuse	30
Retirement	Retirement	21
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	19
Economics/Economic Development	Economics/Economic Development	17
Insurance	Insurance	15
Trade (domestic/foreign)	Trade (domestic/foreign)	9
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	8
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	7
Torts	Torts	6
Government Issues	Government Issues	5
Manufacturing	Manufacturing	5

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Monitor discussions of extension of the 2017 tax law that might impact corporate interests (HR 1) or that might impose new tariffs on dietary supplement ingredients.

Client expense: — · Firm income: $20,000

Matched citations: HR 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · third_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Monitor discussions of extension of the 2017 tax law that might impact corporate interests (HR 1) or that might impose new tariffs on dietary supplement ingredients.

Client expense: — · Firm income: —

Matched citations: HR 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Monitor discussions of extension of the 2017 tax law that might impact corporate interests (HR 1) or that might impose new tariffs on dietary supplement ingredients.

Client expense: — · Firm income: $20,000

Matched citations: HR 1

H.R. 10545118th Congress

American Relief Act, 2025

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments to the SNAP program in the farm bill - farm bill extension continued in American Relief Act. HR 10545

Client expense: — · Firm income: $20,000

Matched citations: HR 10545

Show 21 more cited filings

H.R. 10545118th Congress

American Relief Act, 2025

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Funding for the Food and Drug Administration regulation of dietary supplement products, HR 9027, Fy 2025 Agriculture Appropriations Act, HR 10545- American Relief Act.

Client expense: — · Firm income: $20,000

Matched citations: HR 10545

H.R. 1628118th Congress

CBD Product Safety and Standardization Act of 2023

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: HR 1628

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: HR 1629

H.R. 5967118th Congress

Unemployment Integrity Act of 2023

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Legislation to allow HSA/FSA coverage of dietary supplements (HR 5967, HSA Modernization Act)

Client expense: — · Firm income: $20,000

Matched citations: HR 5967

H.R. 9027118th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Funding for the Food and Drug Administration regulation of dietary supplement products, HR 9027, Fy 2025 Agriculture Appropriations Act, HR 10545- American Relief Act.

Client expense: — · Firm income: $20,000

Matched citations: HR 9027

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: S 1339

S. 2451118th Congress

Hemp Access and Consumer Safety Act

2024 · fourth_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: S 2451

H.R. 1628118th Congress

CBD Product Safety and Standardization Act of 2023

2024 · third_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: HR 1628

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · third_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: HR 1629

H.R. 5967118th Congress

Unemployment Integrity Act of 2023

2024 · third_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Legislation to allow HSA/FSA coverage of dietary supplements (HR 5967, HSA Modernization Act)

Client expense: — · Firm income: $20,000

Matched citations: HR 5967

H.R. 9027118th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025

2024 · third_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Funding for the Food and Drug Administration regulation of dietary supplement products, HR 9027, Fy 2025 Agriculture Appropriations Act

Client expense: — · Firm income: $20,000

Matched citations: HR 9027

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · third_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: S 1339

S. 2451118th Congress

Hemp Access and Consumer Safety Act

2024 · third_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: — · Firm income: $20,000

Matched citations: S 2451

H.R. 5967118th Congress

Unemployment Integrity Act of 2023

2024 · second_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Legislation to allow HSA/FSA coverage of dietary supplements (HR 5967, HSA Modernization Act)

Client expense: — · Firm income: $20,000

Matched citations: HR 5967

H.R. 9027118th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025

2024 · second_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Funding for the Food and Drug Administration regulation of dietary supplement products, HR 9027, Fy 2025 Agriculture Appropriations Act

Client expense: — · Firm income: $20,000

Matched citations: HR 9027

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation being developed to clarify Food and Drug Administration regulation of hemp-derived/CBD products (no bill numbers yet)

Client expense: — · Firm income: $20,000

Matched citations: S 1339

H.R. 2400118th Congress

Reentry Act of 2023

2024 · second_quarter · Client: INDIVIOR INC.

Open original LDA filing ↗

Cited source text and reported amounts

Medicaid Reentry Act - Legislation to allow Medicaid reimbursement for health care services 30 days prior to release from incarceration. HR 2400/ S. 1165).

Client expense: — · Firm income: $30,000

Matched citations: HR 2400

H.R. 4531118th Congress

Support for Patients and Communities Reauthorization Act

2024 · second_quarter · Client: INDIVIOR INC.

Open original LDA filing ↗

Cited source text and reported amounts

Access to medication-assisted therapy for opioid overuse, and the use of telemedicine for provision of services (HR 4531, Support for Patients and Communities Reauthorization/ no Senate number yet )

Client expense: — · Firm income: $30,000

Matched citations: HR 4531

S. 1165118th Congress

Reentry Act of 2023

2024 · second_quarter · Client: INDIVIOR INC.

Open original LDA filing ↗

Cited source text and reported amounts

Medicaid Reentry Act - Legislation to allow Medicaid reimbursement for health care services 30 days prior to release from incarceration. HR 2400/ S. 1165).

Client expense: — · Firm income: $30,000

Matched citations: S. 1165

H.R. 4368118th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024

2024 · first_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860)

Client expense: — · Firm income: $20,000

Matched citations: HR 4368

H.R. 5860118th Congress

Continuing Appropriations Act, 2024 and Other Extensions Act

2024 · first_quarter · Client: UNITED NATURAL PRODUCTS ALLIANCE

Open original LDA filing ↗

Cited source text and reported amounts

Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860)

Client expense: — · Firm income: $20,000

Matched citations: HR 5860

Source: Senate LDA

KNIGHT CAPITOL CONSULTANTS — Lobbying Disclosure | Poliscope